Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error with a standard header and a Home link, indicating the study record is currently blocked from access.SummaryDifference19%

- Check11 days agoChange DetectedThe page shows a revision update from v3.6.6 to v3.7.0, indicating a newer build of the ClinicalTrials.gov page. No substantive study details appear to be altered in this update.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision history now includes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting a small backend or page-tracking update rather than new study information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This is a routine maintenance update that does not change study details or how the page works.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of v3.6.3. This appears to be a minor site/template update and does not modify study data.SummaryDifference0.1%

- Check88 days agoChange DetectedThe study record page revision tag was updated to v3.6.3, indicating a newer release of the page.SummaryDifference0.1%

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.